Nippon Shinyaku Co., Ltd. (4516.T)
JPY 3735.0
(0.89%)
JPY 3735.0
(0.89%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 36.29 Billion JPY | 2.08% |
| 2022 | 34.27 Billion JPY | -6.16% |
| 2021 | 36.59 Billion JPY | 25.39% |
| 2020 | 32.09 Billion JPY | 18.25% |
| 2019 | 25.13 Billion JPY | 2.7% |
| 2018 | 24.96 Billion JPY | 23.4% |
| 2017 | 19.85 Billion JPY | 7.06% |
| 2016 | 17.92 Billion JPY | 69.48% |
| 2015 | 11 Billion JPY | -3.86% |
| 2014 | 11.59 Billion JPY | 2.19% |
| 2013 | 10.74 Billion JPY | 13.36% |
| 2012 | 10.05 Billion JPY | -40.18% |
| 2011 | 9.15 Billion JPY | 4.77% |
| 2010 | 9.06 Billion JPY | -6.43% |
| 2009 | 10.08 Billion JPY | -7.25% |
| 2008 | 10.57 Billion JPY | 11.73% |
| 2007 | 9.75 Billion JPY | 10.74% |
| 2006 | 8.08 Billion JPY | 20.35% |
| 2005 | 6.03 Billion JPY | -14.68% |
| 2004 | 12.73 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 12.54 Billion JPY | 485.35% |
| 2023 Q2 | 10.96 Billion JPY | -13.63% |
| 2023 Q1 | 12.69 Billion JPY | 266.22% |
| 2023 FY | - JPY | 2.08% |
| 2023 Q4 | 3.84 Billion JPY | -66.85% |
| 2023 Q3 | 11.58 Billion JPY | 5.62% |
| 2022 Q3 | 10.35 Billion JPY | 2.67% |
| 2022 Q2 | 10.08 Billion JPY | -14.28% |
| 2022 Q1 | 11.76 Billion JPY | 311.73% |
| 2022 FY | - JPY | -6.16% |
| 2022 Q4 | 3.46 Billion JPY | -66.51% |
| 2021 FY | - JPY | 25.39% |
| 2021 Q3 | 8.41 Billion JPY | 50.38% |
| 2021 Q2 | 5.59 Billion JPY | -68.42% |
| 2021 Q1 | 17.71 Billion JPY | 174.26% |
| 2021 Q4 | 2.85 Billion JPY | -66.04% |
| 2020 FY | - JPY | 18.25% |
| 2020 Q1 | 7.81 Billion JPY | 24.87% |
| 2020 Q3 | 9.93 Billion JPY | 174.08% |
| 2020 Q4 | 6.46 Billion JPY | -34.94% |
| 2020 Q2 | 3.62 Billion JPY | -53.62% |
| 2019 Q2 | 4.77 Billion JPY | -28.42% |
| 2019 Q4 | 6.25 Billion JPY | 28.94% |
| 2019 FY | - JPY | 2.7% |
| 2019 Q3 | 4.85 Billion JPY | 1.68% |
| 2019 Q1 | 6.66 Billion JPY | 52.25% |
| 2018 Q4 | 4.37 Billion JPY | -52.03% |
| 2018 FY | - JPY | 23.4% |
| 2018 Q1 | 5.42 Billion JPY | 240.04% |
| 2018 Q2 | 2.95 Billion JPY | -45.51% |
| 2018 Q3 | 9.12 Billion JPY | 208.73% |
| 2017 Q2 | 4.41 Billion JPY | -19.63% |
| 2017 Q1 | 5.49 Billion JPY | 324.49% |
| 2017 FY | - JPY | 7.06% |
| 2017 Q4 | 1.59 Billion JPY | -75.11% |
| 2017 Q3 | 6.41 Billion JPY | 45.3% |
| 2016 FY | - JPY | 69.48% |
| 2016 Q1 | 4.23 Billion JPY | 137.65% |
| 2016 Q4 | -2.44 Billion JPY | -120.39% |
| 2016 Q3 | 11.99 Billion JPY | 473.37% |
| 2016 Q2 | 2.09 Billion JPY | -50.6% |
| 2015 FY | - JPY | -3.86% |
| 2015 Q4 | 1.78 Billion JPY | -64.55% |
| 2015 Q3 | 5.02 Billion JPY | 226.43% |
| 2015 Q2 | 1.54 Billion JPY | 62.11% |
| 2015 Q1 | 950 Million JPY | -62.86% |
| 2014 FY | - JPY | 2.19% |
| 2014 Q1 | 1.11 Billion JPY | -59.32% |
| 2014 Q2 | 1.32 Billion JPY | 19.19% |
| 2014 Q3 | 4.24 Billion JPY | 219.49% |
| 2014 Q4 | 2.55 Billion JPY | -39.76% |
| 2013 Q3 | 2.82 Billion JPY | 60.0% |
| 2013 FY | - JPY | 13.36% |
| 2013 Q1 | 1.64 Billion JPY | 2.95% |
| 2013 Q2 | 1.76 Billion JPY | 7.56% |
| 2013 Q4 | 2.74 Billion JPY | -2.94% |
| 2012 Q4 | 1.59 Billion JPY | -35.26% |
| 2012 Q1 | 3.88 Billion JPY | 32.15% |
| 2012 Q3 | 2.46 Billion JPY | -24.87% |
| 2012 Q2 | 3.27 Billion JPY | -15.54% |
| 2012 FY | - JPY | -40.18% |
| 2011 Q2 | 3.18 Billion JPY | -14.58% |
| 2011 Q3 | 4.31 Billion JPY | 35.74% |
| 2011 Q4 | 2.93 Billion JPY | -32.01% |
| 2011 FY | - JPY | 4.77% |
| 2011 Q1 | 3.72 Billion JPY | -1.97% |
| 2010 Q3 | 4.54 Billion JPY | 50.68% |
| 2010 Q2 | 3.01 Billion JPY | -32.94% |
| 2010 Q1 | 4.5 Billion JPY | 109.98% |
| 2010 Q4 | 3.79 Billion JPY | -16.49% |
| 2010 FY | - JPY | -6.43% |
| 2009 Q4 | 2.14 Billion JPY | -68.88% |
| 2009 FY | - JPY | -7.25% |
| 2009 Q3 | 6.89 Billion JPY | 105.12% |
| 2009 Q2 | 3.35 Billion JPY | -28.15% |
| 2009 Q1 | 4.67 Billion JPY | 23.94% |
| 2008 Q2 | 2.4 Billion JPY | 0.0% |
| 2008 FY | - JPY | 11.73% |
| 2008 Q3 | 4.59 Billion JPY | 91.34% |
| 2008 Q4 | 3.77 Billion JPY | -17.89% |
| 2007 FY | - JPY | 10.74% |
| 2006 FY | - JPY | 20.35% |
| 2005 FY | - JPY | -14.68% |
| 2004 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.02 Billion JPY | -502.724% |
| Takeda Pharmaceutical Company Limited | 874.6 Billion JPY | 95.851% |
| Sumitomo Pharma Co., Ltd. | -281.07 Billion JPY | 112.911% |
| Shionogi & Co., Ltd. | 186.7 Billion JPY | 80.563% |
| Wakamoto Pharmaceutical Co.,Ltd. | 570.97 Million JPY | -6255.828% |
| Kaken Pharmaceutical Co., Ltd. | 12.26 Billion JPY | -195.834% |
| Eisai Co., Ltd. | 103.1 Billion JPY | 64.803% |
| Morishita Jintan Co., Ltd. | 1.29 Billion JPY | -2706.651% |
| Hisamitsu Pharmaceutical Co., Inc. | 18.34 Billion JPY | -97.874% |
| Mochida Pharmaceutical Co., Ltd. | 8.97 Billion JPY | -304.436% |
| Fuso Pharmaceutical Industries,Ltd. | 3.67 Billion JPY | -888.828% |
| Nippon Chemiphar Co., Ltd. | 1.4 Billion JPY | -2486.6% |
| Tsumura & Co. | 30.77 Billion JPY | -17.932% |
| Kissei Pharmaceutical Co., Ltd. | 18.72 Billion JPY | -93.857% |
| Torii Pharmaceutical Co., Ltd. | 5.27 Billion JPY | -588.484% |
| Towa Pharmaceutical Co., Ltd. | 35.53 Billion JPY | -2.122% |
| Fuji Pharma Co., Ltd. | 6.88 Billion JPY | -427.318% |
| Zeria Pharmaceutical Co., Ltd. | 17.52 Billion JPY | -107.115% |
| KYORIN Holdings, Inc. | 10.29 Billion JPY | -252.467% |
| Taiko Pharmaceutical Co.,Ltd. | -3.75 Billion JPY | 1067.733% |
| Daito Pharmaceutical Co.,Ltd. | 7.55 Billion JPY | -380.471% |
| SymBio Pharmaceuticals Limited | -714 Million JPY | 5182.633% |
| MedRx Co., Ltd | -884.51 Million JPY | 4202.809% |
| Mizuho Medy Co.,Ltd. | 5.53 Billion JPY | -555.493% |
| Solasia Pharma K.K. | -635 Million JPY | 5814.961% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 1628.693% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.16 Billion JPY | -296.049% |
| Sawai Group Holdings Co., Ltd. | 36.87 Billion JPY | 1.581% |
| Cyfuse Biomedical K.K. | -538.28 Million JPY | 6841.732% |
| Toho Holdings Co., Ltd. | 25.84 Billion JPY | -40.414% |
| Koa Shoji Holdings Co.,Ltd. | 5.1 Billion JPY | -611.34% |